NEWPATH MANAGEMENT

newpath-management-logo

Newpath Partners, LP is a life science venture firm dedicated to excellent science and to forming partnerships based on trust and a shared vision.

#SimilarOrganizations #People #Financial #More

NEWPATH MANAGEMENT

Founded:
2018-08-15

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Organization Schema Google Apps For Business


Similar Organizations

cherrystone-angel-group-logo

Cherrystone Angel Group

Providence based angel group interested in biopharma, medical device and tech startups in New England.

polycore-therapeutics-logo

PolyCore Therapeutics

PolyCore Therapeuticsโ€™ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.

Current Employees Featured

daniel-yadegar_image

Daniel Yadegar
Daniel Yadegar CMO & Co-Founder @ Newpath Management
CMO & Co-Founder
2018-09-01

thomas-cahill_image

Thomas Cahill
Thomas Cahill Co-Founder and Managing Partner @ Newpath Management
Co-Founder and Managing Partner

Founder


daniel-yadegar_image

Daniel Yadegar

thomas-cahill_image

Thomas Cahill

Investments List

Date Company Article Money raised
2022-09-07 Orbital Therapeutics Newpath Management investment in Seed Round - Orbital Therapeutics N/A
2021-10-07 Neumora Therapeutics Newpath Management investment in Series A - Neumora Therapeutics 400 M USD
2021-10-05 Exo Therapeutics Newpath Management investment in Series B - Exo Therapeutics 78 M USD
2021-09-03 YourBio Health Newpath Management investment in Venture Round - YourBio Health 21 M USD
2021-07-13 Prime Medicine Newpath Management investment in Series B - Prime Medicine 200 M USD
2021-06-09 Kojin Therapeutics Newpath Management investment in Series A - Kojin Therapeutics 60 M USD
2021-01-06 Myeloid Therapeutics Newpath Management investment in Series A - Myeloid Therapeutics 50 M USD
2020-12-16 Exo Therapeutics Newpath Management investment in Series A - Exo Therapeutics 25 M USD
2019-10-22 Prime Medicine Newpath Management investment in Series A - Prime Medicine 115 M USD

More informations about "Newpath Management" on Search Engine